PolyQuant offers a full service for biomarker studies, starting from optimal sample preparation over first screening studies to optimized assays for the precise quantification of selected protein biomarkers. We offer bioinformatic and statistical support, as well as modern machine learning techniques, to define an optimal set of biomarkers.

PolyQuant has been part of the international biomarker project DecanBio and holds a European patent for detection of bladder cancer from urine samples.